BioMaxima Past Earnings Performance
Past criteria checks 0/6
BioMaxima has been growing earnings at an average annual rate of 11.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 10.7% per year.
Key information
11.9%
Earnings growth rate
19.2%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 10.7% |
| Return on equity | -1.0% |
| Net Margin | -0.9% |
| Next Earnings Update | 29 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How BioMaxima makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 48 | 0 | 18 | 0 |
| 31 Mar 24 | 47 | 0 | 18 | 0 |
| 31 Dec 23 | 47 | 1 | 18 | 0 |
| 30 Sep 23 | 47 | 1 | 17 | 0 |
| 30 Jun 23 | 48 | 2 | 17 | 0 |
| 31 Mar 23 | 61 | 5 | 15 | 0 |
| 31 Dec 22 | 144 | 29 | 17 | 0 |
| 30 Sep 22 | 154 | 31 | 19 | 0 |
| 30 Jun 22 | 155 | 31 | 18 | 0 |
| 31 Mar 22 | 146 | 28 | 18 | 0 |
| 31 Dec 21 | 79 | 10 | 15 | 0 |
| 30 Sep 21 | 79 | 12 | 15 | 0 |
| 30 Jun 21 | 79 | 12 | 14 | 0 |
| 31 Mar 21 | 81 | 14 | 13 | 0 |
| 31 Dec 20 | 61 | 8 | 12 | 0 |
| 30 Sep 20 | 46 | 5 | 11 | 0 |
| 30 Jun 20 | 39 | 3 | 11 | 0 |
| 31 Mar 20 | 30 | 1 | 10 | 0 |
| 31 Dec 19 | 31 | 0 | 10 | 0 |
| 30 Sep 19 | 31 | -1 | 10 | 0 |
| 30 Jun 19 | 31 | -2 | 11 | 0 |
| 31 Mar 19 | 32 | -1 | 11 | 0 |
| 31 Dec 18 | 32 | 0 | 11 | 0 |
| 30 Sep 18 | 32 | 0 | 10 | 0 |
| 30 Jun 18 | 33 | 1 | 10 | 0 |
| 31 Mar 18 | 33 | 1 | 9 | 0 |
| 31 Dec 17 | 33 | 1 | 9 | 0 |
| 30 Sep 17 | 36 | 1 | 11 | 0 |
| 30 Jun 17 | 33 | 1 | 10 | 0 |
| 31 Mar 17 | 30 | 1 | 8 | 0 |
| 31 Dec 16 | 29 | 1 | 8 | 0 |
| 30 Sep 16 | 24 | 1 | 5 | 0 |
| 30 Jun 16 | 24 | 1 | 5 | 0 |
| 31 Mar 16 | 24 | 1 | 6 | 0 |
| 31 Dec 15 | 23 | 1 | 5 | 0 |
| 30 Sep 15 | 22 | 1 | 6 | 0 |
| 30 Jun 15 | 22 | 1 | 6 | 0 |
| 31 Mar 15 | 21 | 1 | 6 | 0 |
| 31 Dec 14 | 22 | 0 | 6 | 0 |
| 30 Sep 14 | 24 | 1 | 6 | 0 |
| 30 Jun 14 | 24 | 1 | 6 | 0 |
| 31 Mar 14 | 23 | 1 | 6 | 0 |
| 31 Dec 13 | 22 | 1 | 5 | 0 |
Quality Earnings: 944 is currently unprofitable.
Growing Profit Margin: 944 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 944 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.9% per year.
Accelerating Growth: Unable to compare 944's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 944 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: 944 has a negative Return on Equity (-0.97%), as it is currently unprofitable.